Liqua-Tox en es it fr

Liqua-Tox Brand names, Liqua-Tox Analogs

Liqua-Tox Brand Names Mixture

  • No information avaliable

Liqua-Tox Chemical_Formula


Liqua-Tox RX_link

Liqua-Tox fda sheet

Liqua-Tox FDA

Liqua-Tox msds (material safety sheet)

Liqua-Tox MSDS

Liqua-Tox Synthesis Reference

Stahmann, et al., U.S. Pat. 2,427,578 (1947)

Liqua-Tox Molecular Weight

308.328 g/mol

Liqua-Tox Melting Point

161 oC

Liqua-Tox H2O Solubility

17 mg/L

Liqua-Tox State


Liqua-Tox LogP


Liqua-Tox Dosage Forms

Powder for solution; Tablet

Liqua-Tox Indication

For the treatment of retinal vascular occlusion, pulmonary embolism, cardiomyopathy, atrial fibrillation and flutter, cerebral embolism, transient cerebral ischaemia, arterial embolism and thrombosis.

Liqua-Tox Pharmacology

Warfarin, a coumarin anticoagulant, is a racemic mixture of two active isomers. It is used in the prevention and treatment of thromboembolic disease including venous thrombosis, thromboembolism, and pulmonary embolism as well as for the prevention of ischemic stroke in patients with atrial fibrillation (AF).

Liqua-Tox Absorption

No information avaliable

Liqua-Tox side effects and Toxicity

LD50=374 (orally in mice)

Liqua-Tox Patient Information

No information avaliable

Liqua-Tox Organisms Affected

Humans and other mammals